Inventor · disambiguated record
John Docherty
Also filed as: DOCHERTY JOHN · DOCHERTY JOHN J
22 granted patents·24 pending applications·270 citations·filing 1987–2025
95Inventor score
Files withPOVIVA CORP28POVIVA TEA LLC8UNIV NORTHEASTERN OHIO5COMPREHENSIVE NEUROSCIENCE INC2UNIV KENT STATE OHIO1
Top patents by PatentIndex Score
46 records- 0196US11666544B1Compositions and methods for treating hypertensionPOVIVA CORP·Filed 2022·Granted Jun 6, 2023·13 cites·18 claims
- 0296US11666543B1Pharmaceutical compositions and methods for treating hypertensionPOVIVA CORP·Filed 2022·Granted Jun 6, 2023·13 cites·16 claims
- 0395US11944635B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2023·Granted Apr 2, 2024·4 cites·29 claims
- 0494US4863900AMethod for reducing viral transmission with poly-L-histidineUNIV NEW YORK STATE RES FOUND·Filed 1987·Granted Sep 5, 1989·129 cites·13 claims
- 0593US12220422B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2024·Granted Feb 11, 2025·1 cites·30 claims
- 0693US12213986B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2024·Granted Feb 4, 2025·1 cites·24 claims
- 0793US12023346B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2023·Granted Jul 2, 2024·2 cites·13 claims
- 0891US11986485B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2023·Granted May 21, 2024·1 cites·22 claims
- 0991US11931369B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2023·Granted Mar 19, 2024·1 cites·12 claims
- 1088US12472236B2Compositions and methods for treating diabetesPOVIVA CORP·Filed 2024·Granted Nov 18, 2025·0 cites·18 claims
- 1188US12397042B2Compositions and methods for treating diabetesPOVIVA CORP·Filed 2024·Granted Aug 26, 2025·0 cites·11 claims
- 1286US11311559B2Compositions and methods for enhanced delivery of antiviral agentsPOVIVA CORP·Filed 2021·Granted Apr 26, 2022·1 cites·21 claims
- 1386US6355692B2Method of inhibiting formation of infectious microorganismsUNIV NORTHEASTERN OHIO·Filed 2000·Granted Mar 12, 2002·25 cites·8 claims
- 1484US2024226033A1Compositions and methods for treating hypertensionPOVIVA CORP·Filed 2024·Application pending·0 cites
- 1583US2025352623A1Compositions and methods for treating diabetesPOVIVA CORP·Filed 2025·Application pending·0 cites
- 1678US7094809B2Method of treating subject infected with Neisseria gonorrheaUNIV KENT STATE OHIO·Filed 2003·Granted Aug 22, 2006·11 cites·3 claims
- 1776US6599945B2Methods for treating subjects infected with a herpes virusUNIV NORTHEASTERN OHIO·Filed 2001·Granted Jul 29, 2003·9 cites·10 claims
- 1874US6197834B1Method of inhibiting formation of infectious herpes virus particlesUNIV NORTHEASTERN OHIO·Filed 1998·Granted Mar 6, 2001·36 cites·16 claims
- 1973US11980593B2Compositions and methods for treating hypertensionPOVIVA CORP·Filed 2022·Granted May 14, 2024·0 cites·20 claims
- 2073US7037945B2Method of inhibiting formation of Neisseria gonorrhea and Neisseria meningiditisUNIV NORTHEASTERN OHIO·Filed 2001·Granted May 2, 2006·4 cites·10 claims
- 2173US6831077B2Augmentation of atypical antipsychotic agent pharmacotherapy with chromium supplementationCOMPREHENSIVE NEUROSCIENCE INC·Filed 2002·Granted Dec 14, 2004·5 cites·12 claims
- 2269US2021235716A1Stable ready-to-drink beverage compositions comprising lipophilic active agentsPOVIVA CORP·Filed 2021·Application pending·0 cites
- 2369US2025161333A1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2025·Application pending·0 cites
- 2466US11700875B1Compositions and methods for sublingual delivery of nicotinePOVIVA CORP·Filed 2022·Granted Jul 18, 2023·0 cites·30 claims
- 2566US2021177978A1Methods for formulating orally ingestible compositions comprising lipophilic active agentsPOVIVA CORP·Filed 2021·Application pending·0 cites
- 2664US2025032516A1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2023·Application pending·0 cites
- 2764US2025387416A1Compositions and methods for treating diabetesPOVIVA CORP·Filed 2024·Application pending·0 cites
- 2863US2023301341A1Compositions and methods for sublingual delivery of nicotinePOVIVA CORP·Filed 2022·Application pending·0 cites
- 2962US7429577B2Augmentation of atypical antipsychotic agent pharmacotherapy with chromium supplementationCOMPREHENSIVE NEUROSCIENCE INC·Filed 2004·Granted Sep 30, 2008·0 cites·17 claims
- 3062US2020008442A1Stable ready-to-drink beverage compositions comprising lipophilic active agentsPOVIVA TEA LLC·Filed 2019·Application pending·0 cites
- 3160US2024009140A1Pharmaceutical compositions and methods for treating hypertensionPOVIVA CORP·Filed 2022·Application pending·0 cites
- 3258US2020178572A1Microwave processing methods for formulating orally ingestible compositions comprising lipophilic active agentsPOVIVA TEA LLC·Filed 2018·Application pending·0 cites
- 3358US2020061195A1Methods for formulating orally ingestible compositions comprising lipophilic active agentsPOVIVA TEA LLC·Filed 2019·Application pending·0 cites
- 3454US2021213091A1Lipophilic active agent infused tobacco leaves and/or tobacco materials and methods of use thereofPOVIVA CORP·Filed 2021·Application pending·0 cites
- 3554US2018116240A1Stable ready-to-drink beverage compositions comprising lipophilic active agentsPOVIVA TEA LLC·Filed 2016·Application pending·0 cites
- 3653US2004235931A1Inhibition of herpes virus replicationFiled 2004·Application pending·0 cites
- 3751US2021145036A1Lipophilic active agent infused compositions with reduced food effectPOVIVA TEA LLC·Filed 2019·Application pending·0 cites
- 3851US2023094827A1Nanoemulsion compositions comprising biologically active ingredientsPOVIVA CORP·Filed 2020·Application pending·0 cites
- 3951US2021145841A1Enhancement of delivery of lipophilic active agents across the blood-brain barrier and methods for treating central nervous system disordersPOVIVA CORP·Filed 2019·Application pending·0 cites
- 4051US2022160731A1Compositions comprising biologically active agents and bile saltsPOVIVA CORP·Filed 2020·Application pending·0 cites
- 4150US2018117161A1Methods for formulating orally ingestible compositions comprising lipophilic active agentsPOVIVA TEA LLC·Filed 2016·Application pending·0 cites
- 4250US2021045998A1Transdermal and/or dermal delivery of lipophilic active agentsPOVIVA CORP·Filed 2019·Application pending·0 cites
- 4350US2021289832A1Lipophilic active agent infused tobacco leaves and/or tobacco materials and methods of use thereofPOVIVA TEA LLC·Filed 2019·Application pending·0 cites
- 4449US2020323773A1Food and beverage compositions comprising pde5 inhibitorsPOVIVA CORP·Filed 2018·Application pending·0 cites
- 4548US5213803AAntiviral composition and methodUNIV NORTHEASTERN OHIO·Filed 1992·Granted May 25, 1993·14 cites·24 claims
- 4648US2021145818A1Compositions infused with nicotine compounds and methods of use thereofPOVIVA TEA LLC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Docherty files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →